Larimar Therapeutics Q3 EPS $(0.61) Misses $(0.40) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings MissesNews
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.40) by 51.36 percent. This is a 154.17 percent decrease over losses of $(0.24) per
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.40) by 51.36 percent. This is a 154.17 percent decrease over losses of $(0.24) per share from the same period last year.